Attenzione: i dati modificati non sono ancora stati salvati. Per confermare inserimenti o cancellazioni di voci è necessario confermare con il tasto SALVA/INSERISCI in fondo alla pagina
CNR Institutional Research Information System
Discovery of causal variants for monogenic disorders has been facilitated by whole exome and genome sequencing, but does not provide a diagnosis for all patients. Here, the authors propose a Full Spectrum of Intolerance to Loss-of-Function (FUSIL) categorization that integrates gene essentiality information to aid disease gene discovery.
The identification of causal variants in sequencing studies remains a considerable challenge that can be partially addressed by new gene-specific knowledge. Here, we integrate measures of how essential a gene is to supporting life, as inferred from viability and phenotyping screens performed on knockout mice by the International Mouse Phenotyping Consortium and essentiality screens carried out on human cell lines. We propose a cross-species gene classification across the Full Spectrum of Intolerance to Loss-of-function (FUSIL) and demonstrate that genes in five mutually exclusive FUSIL categories have differing biological properties. Most notably, Mendelian disease genes, particularly those associated with developmental disorders, are highly overrepresented among genes non-essential for cell survival but required for organism development. After screening developmental disorder cases from three independent disease sequencing consortia, we identify potentially pathogenic variants in genes not previously associated with rare diseases. We therefore propose FUSIL as an efficient approach for disease gene discovery.
Human and mouse essentiality screens as a resource for disease gene discovery
Cacheiro Pilar;MunozFuentes Violeta;Murray Stephen A;Dickinson Mary E;Bucan Maja;Nutter Lauryl M J;Peterson Kevin A;Haselimashhadi Hamed;Flenniken Ann M;Morgan Hugh;Westerberg Henrik;Konopka Tomasz;Hsu ChihWei;Christiansen Audrey;Lanza Denise G;Beaudet Arthur L;Heaney Jason D;Fuchs Helmut;GailusDurner Valerie;Sorg Tania;Prochazka Jan;Novosadova Vendula;Lelliott Christopher J;WardleJones Hannah;Wells Sara;Teboul Lydia;Cater Heather;Stewart Michelle;Hough Tertius;Wurst Wolfgang;Sedlacek Radislav;Adams David J;Seavitt John R;TocchiniValentini Glauco;Mammano Fabio;Braun Robert E;McKerlie Colin;Herault Yann;de Angelis Martin Hrabe;Mallon AnnMarie;Lloyd K C Kent;Brown Steve D M;Parkinson Helen;Meehan Terrence F;Smedley Damian;Ambrose J C;Arumugam P;Baple E L;Bleda M;BoardmanPretty F;Boissiere J M;Boustred C R;Brittain H;Caulfield M J;Chan G C;Craig C E H;Daugherty L C;de Burca A;Devereau A;Elgar G;Foulger R E;Fowler T;FurioTari P;Hackett J M;Halai D;Hamblin A;Henderson S;Holman J E;Hubbard T J P;Ibanez K;Jackson R;Jones L J;Kasperaviciute D;Kayikci M;Lahnstein L;Lawson K;Leigh S E A;Leong I U S;Lopez F J;MaleadyCrowe F;Mason J;McDonagh E M;Moutsianas L;Mueller M;Murugaesu N;Need A C;Odhams C A;Patch C;PerezGil D;Polychronopoulos D;Pullinger J;Rahim T;Rendon A;RiesgoFerreiro P;Rogers T;Ryten M;Savage K;Sawant K;Scott R H;Siddiq A;Sieghart A;Smith K R;Sosinsky A;Spooner W;Stevens H E;Stuckey A;Sultana R;Thomas E R A;Thompson S R;Tregidgo C;Tucci A;Walsh E;Watters S A;Welland M J;Williams E;Witkowska K;Wood S M;Zarowiecki M;Marschall Susan;Lengger Christoph;Maier Holger;Seisenberger Claudia;Buerger Antje;Kuehn Ralf;Schick Joel;Hoerlein Andreas;Oritz Oskar;Giesert Florian;Beig Joachim;Kenyon Janet;Codner Gemma;Fray Martin;Johnson Sara J;Cleak James;SzokeKovacs Zsombor;Lafont David;Vancollie Valerie E;McLaren Robbie S B;HughesHallett Lena;Rowley Christine;Sanderson Emma;Galli Antonella;Tuck Elizabeth;Green Angela;Tudor Catherine;Siragher Emma;Dabrowska Monika;Mazzeo Cecilia Icoresi;Griffiths Mark;Gannon David;Doe Brendan;Cockle Nicola;Kirton Andrea;Bottomley Joanna;Ingle Catherine;Ryder Edward;Gleeson Diane;RamirezSolis Ramiro;Birling MarieChristine;Pavlovic Guillaume;Ayadi Abdel;Hamid Meziane;About Ghina Bou;Champy MarieFrance;Jacobs Hugues;Wendling Olivia;Leblanc Sophie;Vasseur Laurent;Chesler Elissa J;Kumar Vivek;White Jacqueline K;Svenson Karen L;Wiegand JeanPaul;Anderson Laura L;Wilcox Troy;Clark James;Ryan Jennifer;Denegre James;Stearns Tim;Philip Vivek;Witmeyer Catherine;Bates Lindsay;Seavey Zachary;Stanley Pamela;Willet Amelia;Roper Willson;Creed Julie;Moore Michayla;Dorr Alex;Fraungruber Pamelia;Presby Rose;Mckay Matthew;NguyenBresinsky Dong;Goodwin Leslie;Urban Rachel;Kane Coleen
2020
Abstract
The identification of causal variants in sequencing studies remains a considerable challenge that can be partially addressed by new gene-specific knowledge. Here, we integrate measures of how essential a gene is to supporting life, as inferred from viability and phenotyping screens performed on knockout mice by the International Mouse Phenotyping Consortium and essentiality screens carried out on human cell lines. We propose a cross-species gene classification across the Full Spectrum of Intolerance to Loss-of-function (FUSIL) and demonstrate that genes in five mutually exclusive FUSIL categories have differing biological properties. Most notably, Mendelian disease genes, particularly those associated with developmental disorders, are highly overrepresented among genes non-essential for cell survival but required for organism development. After screening developmental disorder cases from three independent disease sequencing consortia, we identify potentially pathogenic variants in genes not previously associated with rare diseases. We therefore propose FUSIL as an efficient approach for disease gene discovery.
Istituto di Biochimica e Biologia Cellulare - IBBC
Discovery of causal variants for monogenic disorders has been facilitated by whole exome and genome sequencing, but does not provide a diagnosis for all patients. Here, the authors propose a Full Spectrum of Intolerance to Loss-of-Function (FUSIL) categorization that integrates gene essentiality information to aid disease gene discovery.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.14243/410042
Citazioni
ND
ND
59
social impact
Conferma cancellazione
Sei sicuro che questo prodotto debba essere cancellato?
simulazione ASN
Il report seguente simula gli indicatori relativi alla propria produzione scientifica in relazione alle soglie ASN 2023-2025 del proprio SC/SSD. Si ricorda che il superamento dei valori soglia (almeno 2 su 3) è requisito necessario ma non sufficiente al conseguimento dell'abilitazione. La simulazione si basa sui dati IRIS e sugli indicatori bibliometrici alla data indicata e non tiene conto di eventuali periodi di congedo obbligatorio, che in sede di domanda ASN danno diritto a incrementi percentuali dei valori. La simulazione può differire dall'esito di un’eventuale domanda ASN sia per errori di catalogazione e/o dati mancanti in IRIS, sia per la variabilità dei dati bibliometrici nel tempo. Si consideri che Anvur calcola i valori degli indicatori all'ultima data utile per la presentazione delle domande.
La presente simulazione è stata realizzata sulla base delle specifiche raccolte sul tavolo ER del Focus Group IRIS coordinato dall'Università di Modena e Reggio Emilia e delle regole riportate nel DM 589/2018 e allegata Tabella A. Cineca, l'Università di Modena e Reggio Emilia e il Focus Group IRIS non si assumono alcuna responsabilità in merito all’uso che il diretto interessato o terzi faranno della simulazione. Si specifica inoltre che la simulazione contiene calcoli effettuati con dati e algoritmi di pubblico dominio e deve quindi essere considerata come un mero ausilio al calcolo svolgibile manualmente o con strumenti equivalenti.